A new review article says it’s time to refine current adverse drug event adjudication methods to fit deprescribing studies.
Ross S, et al. Adverse Drug Events in Older Adults: Review of Adjudication Methods in Deprescribing Studies. J Am Geriatr Soc. 2020; doi: 10.1111/jgs.16382 A
Medication Fog Can Mimic or Worsen Dementia in the Elderly
“Potentially” is the key word — the drugs on the list don’t always pose a problem, and no one should stop using any medicine without first checking with a doctor because that could do serious …
USDeN Annual Meeting: Submit an Abstract
We strongly encourage and invite you to present at the USDeN annual meeting poster session; this may be a repeat or encore poster from AGS
Eliminating Medication Overload: A National Action Plan from the Lown Institute
Medication overload is an epidemic among older Americans. Every day, 750 Americans age 65 and over are hospitalized for a side effect caused by one
New Clinical Investigation: Physician Perspectives on Deprescribing Cardiovascular Medications for Older Adults
Reasons for considering deprescribing cardiovascular medications, by specialty. Goyal P, Anderson TS, et al. Physician Perspectives on Deprescribing Cardiovascular Medications for Older Adults. J Am
AGING Initiative Multiple Chronic Conditions (MCC) Scholars Program now accepting applications
The AGING Initiative, an NIH-funded initiative designed to bridge the Health Care Services Research Network and the network of Claude D. Pepper Older Americans Independence
Launch of the US Deprescribing Research Network
We are pleased to announce the launch of the US Deprescribing Research Network (USDeN)! Funded by the US National Institute on Aging, the network is
